BPC-157 Reconstitution Calculator

What is BPC-157?

BPC-157 (Body Protection Compound) is a synthetic 15-amino-acid peptide derived from a partial sequence of a protein identified in human gastric juice. It has been studied in preclinical animal research for its effects on tissue repair, angiogenesis, and gastrointestinal healing, with published work exploring tendon, ligament, muscle, and gut injury models. Most of the existing research is from rodent studies; human clinical data remains limited. BPC-157 is not approved by the FDA for human use and has been flagged by the World Anti-Doping Agency (WADA) as a prohibited substance in sport. Research-grade BPC-157 sold by chemical supply companies is labeled for laboratory research purposes only.

Common vial sizes

Research vendors commonly offer BPC-157 in 2 mg, 5 mg, and 10 mg lyophilized vials. A 5 mg vial reconstituted with 3 mL of bacteriostatic water yields approximately 1,667 mcg/mL.

• 2 mg vial
• 5 mg vial
• 10 mg vial

Reconstitution examples

Worked examples showing exactly what a given vial, bacteriostatic water volume, and target dose produce in syringe units. All math is from the same calculator above.

• 5 mg vial + 2 mL bacteriostatic water → 2500 mcg/mL concentration.
  A 250 mcg dose = 10 units on a u-100 insulin, 1 ml (100 units) (0.1 mL).
• 5 mg vial + 3 mL bacteriostatic water → 1666.67 mcg/mL concentration.
  A 250 mcg dose = 15 units on a u-100 insulin, 1 ml (100 units) (0.15 mL).
• 5 mg vial + 5 mL bacteriostatic water → 1000 mcg/mL concentration.
  A 500 mcg dose = 50 units on a u-100 insulin, 1 ml (100 units) (0.5 mL).
• 10 mg vial + 5 mL bacteriostatic water → 2000 mcg/mL concentration.
  A 500 mcg dose = 25 units on a u-100 insulin, 1 ml (100 units) (0.25 mL).

Storage & shelf life

Lyophilized BPC-157 is generally stored refrigerated at 2–8 °C or frozen for longer-term storage. Published laboratory handling notes report that reconstituted solutions are typically kept refrigerated and protected from light.

Reported half-life

Published preclinical pharmacokinetic work reports a short plasma half-life on the order of a few hours, though effects measured in tissue-healing models often extend beyond the circulating half-life.